International consortium aims to revolutionise viral vector manufacturing
A groundbreaking collaboration between leading biotechnology companies and research organisations in the UK and Canada has secured £1.1 million in funding to develop a next-generation cell platform for viral vector production. The project, led by VVector Bio and including the National Research Council of Canada (NRC), Revvity, and Abselion, aims to address critical bottlenecks in […]